Global Drug Access For Rare Diseases With Aayush Goyal of MedsPartner

Send us Fan MailImagine discovering that a life-saving treatment for your rare condition exists — but you can’t get it because it’s not available or affordable in your country. That’s the reality for countless families around the world.In this global episode of Rare Connection, host Joanna Ball sits down with Aayush Goyal, founder of MedsPartner, a platform that helps patients legally access medications from other countries through the named patient import pathway.We cover: 🔹 The rare disease drug access crisis across borders 🔹 How MedsPartner helps navigate regulatory challenges 🔹 The hidden legal system most doctors and patients don’t know about 🔹 Real stories of families who found hope when doors seemed closed 🔹 How advocates can spread the word about this life-saving option🌍 Learn more about MedsPartner: https://www.medspartner.com 📝 Contact: [email protected] 📲 Follow: @medspartner on social media🎙️ Listen to Rare Connection on Apple Podcasts, Spotify, Amazon Music & more 🎥 Watch more episodes here on the Rare Chef YouTube channel 🧡 Support the show: Buy Me a Coffee⚠️ Trigger Warning: This episode includes discussions about treatment barriers, health inequity, and medical frustration.🆘 If you are in crisis or need emotional support: 📞 Call or text 988 in the U.S. 📱 Or text HOME to 741741 for the Crisis Text Line You are not alone.#RareDisease #GlobalHealth #MedsPartner #DrugAccess #NamedPatient #JoannaBall #RareConnectionPodcastChapter Markers00:00 intro01:57 What inspired Ayush to create Meds Partner?04:21 How big is the drug access problem globally?08:53 What conditions most people reach out about?10:30 What is Named Patient Importation and how does it work?14:39 Problems with doctors not knowing about the program17:11 Risks and Misunderstandings2048 Is a doctor allowed to prescribe a med that isn't available in their country?22:01 Examples of impact on rare disease families24:55 Which countries are the most challenging and which are getting it right?26:26 biggest opportunities for policy change29:25 Raising awareness for this access option32:02 Hopes in terms of collaboration & support34:03 current projects35:17 ConclusionSupport the show